Multifunctional nanovesicles enhance antitumour activity of paclitaxel and carboplatin against ovarian cancer by inactivating JMJD3-HER3 axis

Jingxin  Mo; Li Wang; Jun Wu; Lee Yong Lim; Wei Zhao

Multifunctional nanovesicles enhance antitumour activity of paclitaxel and carboplatin against ovarian cancer by inactivating JMJD3-HER3 axis

Jingxin Mo, Li Wang, Jun Wu, Lee Yong Lim, Wei Zhao

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Publication status	Published - 2018
Event	1st Controlled Release Asia Meeting - Matrix Building - Biopolis , Singapore, Singapore Duration: 24 Sept 2018 → 25 Sept 2018 http://www.crsaustralia.org/controlled-release-asia-meeting/

Conference

Conference	1st Controlled Release Asia Meeting
Country/Territory	Singapore
City	Singapore
Period	24/09/18 → 25/09/18
Internet address	http://www.crsaustralia.org/controlled-release-asia-meeting/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{48568d818bfe491bb0d4b8fc3b325e03,

title = "Multifunctional nanovesicles enhance antitumour activity of paclitaxel and carboplatin against ovarian cancer by inactivating JMJD3-HER3 axis",

author = "Jingxin Mo and Li Wang and Jun Wu and Lim, {Lee Yong} and Wei Zhao",

year = "2018",

language = "English",

note = "1st Controlled Release Asia Meeting ; Conference date: 24-09-2018 Through 25-09-2018",

url = "http://www.crsaustralia.org/controlled-release-asia-meeting/",

}